Finally, the genetic map will provide information important to the task of spanning large regions of the chromosome by physical methods now being developed (14, 15) . The defined loci will provide essential reference points for studies that seek to "walk"along the X chromosome. Genet. 36, 546 (1984). 20. R. Nussbaum, W. Crowder, W. Nyhan, C. T.
Caskey, Proc. Natl. Acad. Sci. U.S. A. 80, 4035 (1983) . 21. D. Page et al., ibid. 79, 5352 (1982) . 22. K. Davies et al., Nucleic Acids Res. 11, 2302 .
23. R. Rozen, J. Fox W. Fenton, A. Horw.Ih, L.
Rosenberg, Nature (London) 313, 815 (1985) . 24. B. Bakker and P. Pearson, personal comrnunication. 25 . L. Kurkel, personal communication. (Blackwell, Oxford, ed. 6, 1975) Tissue-specific phenotypes result from a sequence of developmental stages. Totipotent cells in the early embryo give rise to stem cells specific to three distinct layers-endoderm, ectoderm, and mesoderm. Although the lineage, or progression from stem cell to tissue-specific phenotype is not always fixed (1) , once a cell is determined, it is generally destined for specialization along a specific pathway, such as erythropoiesis or myogenesis. The option to generate other phenotypes no longer exists for the determined vertebrate cell, and its progeny stably inherit its limited potential. The determined cell will give rise to other phenotypes only under unusual experimental conditions, such as at sites of regeneration in amphibian limbs where transdifferentiation has occurred or after treatment with a drug such as 5-azacytidine; even then, only derivatives of the same embryonic lineage are obtained (2) . At some point in development, the determined cell expresses its phenotype, and the genes necessary for its role in the function of a particular tissue are transcribed.
R. Race and R. Sanger, Blood Groups in Man
To obtain tissue-specific phenotypes, a sequence of regulatory mechanisms must exist that determine when in a 758 cell's history specific genes are transcribed. The genetic composition of eukaryotic cells is generally stable and heritable. Chromosomes are not lost in the course of cell specialization. This is evident since entire frogs can be generated from the transplantation of nuclei of specialized intestine cells into enucleated oocytes and since a diversity of normal tissue-specific cell types can be generated from malignant tumor cells introduced into early mouse embryos (3) . The current model for the differential expression of genes characteristic of tissues at different points in development requires regulation by DNA sequences on the same chromosome (cis-acting) and on different chromosomes (trans-acting). Cis-acting DNA sequences that impart tissue-specific regulation have been identified from the study of the expression of cloned genes after transfection into cultured cells (4) . The diffusible products of trans-acting genes are assumed to be negative or positive regulators of the cis-acting gene sequences. Although some general mediators of gene transcription and gene-specific binding proteins have been characterized in eukaryotes (5) , with the exception of the factors that bind the Drosophila alcohol dehydrogenase gene (6) (8, 9) .
Heterokaryons: A Model System for Studying Ceil Specialization
To study the mechanisms regulating cell specialization, we developed a system in which nonmuscle cells can be induced to express muscle genes predictably and stably. We combine entire muscle cells with cells of other phenotypes and from other species through the use of polyethylene glycol. In these fused cells, or heterokaryons, expression of previously silent muscle genes is activated in response to tissue-specific factors present in muscle (10) (11) (12) . The nuclear composition of the heterokaryons and the activation of genes can be determined by taking advantage of speciesspecific differences: the nonmuscle cells used are always human and the muscle cells are always mouse. Furthermore, the fusion product is stable; in contrast with typical interspecific hybrids (synkaryons), cell division does not occur and the parental cell nuclei remain intact and retain a full complement of chromosomes. Finally, changes in gene expression can be assayed immediately after fusion and monitored for relatively long periods thereafter.
We have shown that muscle genes are activated in nonmuscle nuclei upon fusion with muscle. This activation must be mediated -by diffusible, trans-acting molecules that are transported to nuclei through the cytoplasm, since the nuclei of the two cell types remain separate and distinct. These results show that gene expression by nuclei of highly specialized cells is remarkably plastic. Thus, the muscle genes in cells with very different roles (skin, cartilage, lung, and liver) are receptive to activation by muscle regulatory factors. The differences in the requirements for gene activation in these cell types provide insight into the molecular mechanisms that lead to the generation and maintenance of phenotypes.
Gene Activation in Heterokaryons
The mouse muscle cell line used to produce heterokaryons is a diploid subclone, C2C12 (13) . To test the influence of histogenetic state and of in vivo aging on muscle gene expression, heterokaryons were produced with mouse muscle and eight different human nonmuscle cell types, including keratinocytes (ectoderm), chondrocytes and fibroblasts (mesoderm), and hepatocytes (endoderm) (14) . In addition, the four strains of fibroblasts used were either from different tissues (amniotic fluid, skin, and lung) or In each case tested, human muscle genes were activated (Table 1) . Human myosin light chains-ls, 2s, 2f, and fetal-and human isozymes of creatine kinse (CK)-MB, MM, and a functional mouse-human hybrid MM-were distinguished from their mouse muscle counterparts by their mobility upon gel electrophoresis; their identities were confirmed either by reaction with monoclonal antibodies on Western blots or by in situ assays of enzyme activity (10, 19) . The human muscle-specific transcripts of two sarcomeric actin genes, a-cardiac and a-skeletal actin, were detected by Northern blot and S1 nuclease analysis with species-and isotype-specific complementary DNA (cDNA) and genomic DNA probes (20) . Expression of the human muscle-specific cell surface antigens, 24.1D5 and 5.1H11, was induced and could be monitored on single heterokaryons with monoclonal antibodies (11, Fig. 2 . Activation of human muscle gene for 5.lH1l in heterokaryons. Live cells were incubated with monoclonal antibody to 5.lHll followed by biotin conjugated to an antimouse antibody and avidin conjugated to Texas red. Heterokaryons are shown in fluorescence microscopy at two different wavelengths. The binucleate heterokaryon containing one punctate mouse muscle nucleus and one uniformly stained human hepatocyte nucleus expresses the antigen, which is uniformly distributed on the cell surface. The trinucleate heterokaryon (lower center) has not activated the gene for 5.1H1. 17, 21, 22) . Thus, the genes that were activated encoded diverse products: enzymes critical to energy production, structural components of the contractile apparatus, and cell surface components. The relative amounts and sequence of expression of these different muscle gene products in heterokaryons paralleled myogenesis in pure cultures of human muscle cells.
The Kinetics of Gene Expression Differ
We examined the time course and frequency of muscle gene expression in different cell types contained in heterokaryons. The proportion of individual heterokaryons expressing the cell surface antigen 5. lHI 1 was determined between 1 and 15 days after fusion in 19 independent experiments in which more than 7000 individual heterokaryons were analyzed (Fig. 3) . The three distinct patterns observed differed in the time course of gene expression, primarily because of differences in the lag period before 5.1H 1I could be detected. In addition, the ultimate frequency of gene expression differed among cell types and approximated 95, 60, and 25 percent for fibroblasts, keratinocytes, and hepatocytes, respectively. Thus, tissue derivation and possibly embryonic origin have marked effects: fibroblasts, which are from the same embryonic lineage as muscle (mesoderm), exhibit faster kinetics and a higher ultimate frequency of 5. IHI I expression than keratinocytes (ectoderm) and hepatocytes (endoderm) . In contrast, the kinetic curves for skin fibroblasts from two developmental stages were indistinguishable (16, 17) .
To test whether the differences in the kinetics of 5. IHI I accumulation were due to phenotypic differences in the translation and subsequent processing of a cell surface protein, the expression of another muscle gene was examined at the transcriptional level. The relative levels of the messenger RNA's (mRNA's) for the muscle-specific a-cardiac and a-skeletal actins were studied in mass cultures of heterokaryons. We used species-and isotype-specific cDNA probes that recognize the transcripts of -the human a-cardiac and a-skeletal actin genes, respectively, but not those of mouse or of other actin genes (23) . Both a-cardiac and a-skeletal actin expression was evident in heterokaryons, and the time course and relative levels of the two transcripts differed (Fig. 4) . These differences in sarcomeric actin expression were similar to those observed in pure cultures of human muscle cells (20) . With this assay we compared the kinetics of accumulation of actin transcripts in heterokaryons produced with keratinocytes and with fibroblasts. The results paralleled those obtained for 5.1Hl1 expression. a-Cardiac actin transcripts were not detectable in keratinocyte heterokaryons on days 1 and 2 after fusion, when the levels in fibroblast heterokaryons were marked. By day 5, transcripts were detectable in keratinocyte heterokaryons as well (16) . Since the differences in kinetics observed at the protein level were also observed at the mRNA level, they probably reflect differences among cell types in steps necessary for the activation of gene expression.
Mechanisms for Gene Activation
To examine potential mechanisms required for gene activation, we determined whether DNA replication was necessary to reprogram cells from different stages of development and of different phenotypes to express muscle genes (11, 16, 17) . We exposed nonmuscle cells to the DNA synthesis inhibitor cytosine arabinoside (Ara-C) before and after fusion. The expression of human muscle CK was assayed in extracts of whole cells, and the expression of 5. lHl was monitored on individual heterokaryons. The human M-CK gene was activated in all of the seven nonmalignant cell types tested, and three novel CK isozymes containing this subunit were detected: human MB, human MM, and mousehuman hybrid MM (Fig. 5) . In all cases, similar amounts of the human isozymes were present regardless of whether DNA synthesis was inhibited. Furthermore, inhibition of DNA synthesis also had no effect on the frequency of 5. 1Hl 1 expression at the single-cell level. These results suggest that alterations in chromatin configuration requiring DNA replication are not necessary for the muscle genes in these cell types to be accessible to and respond to regulatory factors present in differentiated muscle cells.
In contrast to these results, CK and 5. lHl 1 muscle gene expression were never observed when we formed heterokaryons with HeLa cells, a malignant, aneuploid cell type (12) . We examined whether prior treatment with 5-azacytidine (SAc), a drug thought to reduce gene methylation (24) (Fig. 5 ) or in 5Ac-treated HeLa cells fused to themselves (12) . Therefore gene activation in HeLa cells appears to require a mechanistic step not required by the other cell types tested: first a change induced by SAc is necessary and then interaction with muscle gene regulators.
Gene Dosage Influences Gene Expression
Further differences among cell types in the activation of muscle genes were apparent when we examined the effects of gene dosage, or nuclear ratio, on the frequency of muscle gene expression Heterokaryons formed between mouse muscle cells and fibroblasts from amniotic fluid F(A), lung F(L), fetal skin F(FS), and adult skin F(AS), keratinocytes (K), chondrocytes (C), and hepatocytes (H) are shown. Cultures marked + were exposed to cytosine arabinoside (Ara-C) for 24 hours before and 24 hours after fusion to ensure inhibition of DNA synthesis. Cultures marked -were not exposed to Ara-C during this period. Heterokaryons formed between mouse muscle cells and HeLa cells were either untreated (-) or exposed to 5 FM of 5-azacytidine (5-Ac) for 3 days followed by 1 day of drug removal (+). Equivalent enzyme activities were loaded in each lane. Arrows indicate CK isozymes containing human M subunits. Abbreviations: BB is the nonmuscle isozyme, M-subunit synthesis is initiated early in differentiation, and the dimers MB and MM are characteristic of differentiated muscle. (25) . Nuclear composition and the expression of the human muscle cell surface antigen 5.1Hl1 were monitored in the same heterokaryons with fluorescence microscopy at two different wavelengths (Fig. 2) . The results for heterokaryons of different nuclear composition were pooled into five groups according to nuclear ratio, or the relative number of muscle to nonmuscle nuclei they contained (Fig. 6 ). The proportion in each group that expressed the antigen on a given day was determined. Examples for the 6-day time point are shown, beyond which the pattern of gene expression did not change.
The effect of gene dosage on 5.1H11 expression differed markedly for the three cell types. For fibroblasts, a high proportion of heterokaryons (95 percent) expressed 5.lHl1 at all nuclear ratios, except in the increased fibroblast group (1: > 2), in which it was -70 percent. In keratinocyte heterokaryons, gene expression in the 1:1 nuclear ratio group never exceeded 30 percent, whereas increased proportions of either muscle or keratinocyte nuclei resulted in the maximum expression of 70 percent. For hepatocyte heterokaryons, the frequency of gene expression was greatest (50 percent) when the relative number of muscle nuclei was increased and lowest (5 percent) when the proportion of hepatocyte nuclei was increased.
Although the interaction between two disparate cell types combined by fusion is likely to be complex, some noteworthy relationships are apparent from the studies ofgene dosage (16, 25 (ii) The kinetics of gene expression in fibroblast heterokaryons with increased proportions of nonmuscle nuclei were slower than when the nuclear ratio was 1:1. These results could be due to a requirement for gene activation of a threshold concentration of positive regulators: increased time would be necessary for the progressive accumulation of factors that must be shared among fibroblast nuclei. The rate with a 1:1 nuclear ration exceeded that with increased muscle nuclei for fibroblast heterokaryons, which suggests that increased input from muscle was not optimal; instead a balance offactors contributed by each cell type might be required.
In hepatocyte heterokaryons, the frequency of activation of muscle gene expression was lowest when the proportion of hepatocyte nuclei was increased and highest when the proportion of muscle nuclei was increased. That these frequencies did not change with time suggests that gene expression was determined by the continued balance between components contributed by each cell type. Keratinocytes were more frequently activated to express muscle genes when either the proportion of keratinocyte or of muscle nuclei was increased in heterokaryons. The increased frequency of gene expression in heterokaryons with excess keratinocyte nuclei could be due to the existence of subpopulations of cells in keratinocyte cultures that differed in their ability to respond to muscle regulatory factors. Accordingly, the chance of obtaining a keratinocyte in which activation could occur would increase with the number of keratinocyte nuclei. Stratification within colonies of keratinocytes was evident in our cultures, and although the upper, more mature cells reportedly do not replate well (26) , possibly some were incorporated into heterokaryons.
Expression of the Nonmuscle Phenotype
To test whether the phenotype of the nonmuscle cell persists in heterokaryons, we monitored the expression of albumin in individual hepatocyte heterokaryons. Six days after fusion, when the muscle product 5. lH1 1 was expressed at maximum frequency, albumin was still present in a large proportion of hepatocyte heterokaryons. By 15 days after fusion 5.lHlI was still expressed at maximal frequency, but the proportion of albumin-containing heterokaryons was reduced. The persistence of albumin at 6 days was not due to the stability of previously synthesized proteins, since albumin is secreted within a few hours of its production. To detect albumin in heterokaryons, we had to inhibit secretion with monensin 2.5 hours before fixation (16, 17 (20, (27) (28) (29) . The amount of a-cardiac actin mRNA in each sample was normalized to the amount present in a human heart standard analyzed at the same time. In the mouse muscle C2C12 cultures, acardiac actin transcripts accumulated rapidly, transiently peaked at a level comparable to 50 percent of the a-cardiac actin mRNA expressed in human heart within 24 hours, and declined (Table 2). In contrast, a-cardiac actin transcripts accumulated steadily in human myotubes over a 6-day period and exceeded the peak reached in the C2C12 cell line 16-fold, a level comparable to 800 percent that observed in human heart. In heterokaryon cultures, the time course of human transcript accumulation and the amount of transcript per nonmuscle nucleus were similar to those observed in pure human, not mouse, muscle cultures. Of greatest surprise was the result obtained for mouse a-cardiac actin mRNA in heterokaryons: instead of continuing to decline, as in pure mouse muscle cultures, the amount of mouse transcripts increased after heterokaryon formation.
These findings suggest that the human a-cardiac actin gene responds to mouse muscle cytoplasmic factors by producing transcripts with the time course and at levels typical of human, not mouse, muscle cultures. These differences in transcript accumulation could arise in part from differences in the cis-acting regulatory regions of the mouse and human acardiac actin genes. In addition, the results are compatible with the hypothesis that trans-acting mouse muscle factors activate human muscle regulatory genes encoding factors that, in turn, act on mouse muscle genes or stabilize mouse a-cardiac actin transcripts. Finally, the "activated" phenotype seems to dominate, since the usual decline in the amount of mouse a-cardiac actin transcripts is overridden by the presence of the human nuclei.
Muscle Gene Regulators at Distnct Stages of Development
Like the experiments described above, the majority of studies of gene expression in specialized cells have utilized the differentiated stage of development (Fig. 1) . This is true primarily because for all cell types, this stage is generally the best characterized and. most readily obtained in tissue culture. 15 NOVEMBER 1985 Table 2 . Relative a-cardiac actin mRNA in pure muscle and in heterokaryon cultures. PEG treatment occurred after the mouse muscle myotubes had been in fusion medium for 3 days. Thus, to compare the mouse time scale in fusion medium (left) with that after PEG treatment (right), add 3 days. (22) . Convenient markers for this study were provided by two cell-surface antigens: 5.AH1I and 24.1D5. The 5.AHl1 antigen is expressed on cultured myoblasts to some extent, but markedly increases in amount on myotubes. The 24. lD5 antigen is detected only on myoblasts and is no longer present once myoblasts fuse to form multinucleated differentiated myotubes. The human forms of both muscle cell-surface components were recognized with speciesspecific monoclonal antibodies (17, 20) . The 24. 1D5 antigen was detected only in myoblast heterokaryons (22 percent) (Table 3 (8) . Studies of maturation have been hindered because these transitions Table 3 . Evidence for two temporally distinct muscle gene regulators. Fetal skin fibroblasts were used except in myotube experiment 3, in which lung fibroblasts were used; S.E.M., standard error of the mean. (33) or modulation of gene expression by activators and repressors (34) with additional complex regulatory effects resulfing from the relative concentration and affinity of these factors for specific sequences within genes (4) (5) (6) . Some major questions are raised by these theories: How fixed and irreversible is the differentiated state or tissue-specific phenotype of a cell? What is required to maintain the differentiated state? What underlying molecular mechanisms regulate the transition from the determined to the differentiated to the mature cell phenotype? Do these mechanisms differ for different specialized cell types?
Our approach to these questions was inspired by reports by Weiss and others of experiments with somatic cell hybrids, in which the expression of genes atypical of a cell's normal phenotype could be induced (35, 36) . A limitation in the comparative analysis of gene activation in different cell types is that highly Fig. 7 ancuploid transformed cells were usually used. In addition, hybrid cells were frequently obtained after proliferation in mitogen-rich media, which led to variable retention and rearrangement of genetic material (35, 37) , both of which are likely to have influenced gene expression (38) . As a result, certain phenotypes were thought to be incapable of being activated, because of either their specialized state or their developmental stage (37, 39) .
The activation of muscle gene expression in all of the eight nonmuscle cell types we tested is likely to be due to several factors. To facilitate the study of normal regulatory mechanisms, most nonmuscle cells were diploid primary cells. To overcome the problems of gene loss and rearrangement, we used a heterokaryon system that remained stable for the 2-week life-span of the cells and permitted a systematic analysis of gene expression over time. We cannot rule out the possibility that muscle is particularly well suited for intemuclear communication and existence as a heterokaryon, since it is naturally a multinucleated cell in its differentiated state. However, the use of culture conditions which promoted muscle differentiation, not cell division, was probably critical to the success of our experiments. Proliferation and differentiation are antagonistic, mutually exclusive states in muscle cells (40) . Furthermore, specific culture conditions that differ markedly among cell types are required for the optimal expression of phenotypes in vitro (41) 15 NOVEMBER 1985 reprogramming of the nonmuscle nucleus in a heterokaryon results in the synthesis by that nucleus of muscle regulatory factors. Thus, from an analysis of the combined effects on gene expression of two cell types fused to form heterokaryons, inferences regarding the regulators that generate and maintain these phenotypes can be drawn.
Gene expression in cells specialized for very different functions is not fixed and irreversible. Although under normal circumstances the pattern of gene expression of specialized cells is stable and heritable, it can be altered if the regulatory circuits between nucleus and cytoplasm are disrupted. Thus, changes in gene expression during development depend not only on the nucleus, but also on the cytoplasm, which plays an essential role as signal transducer. Our results extend the observations that nuclear gene expression is subject to modulation by the cytoplasm (43) to a system that may be particularly amenable to molecular analysis.
Future Prospects
Heterokaryons have utility as experimental models for investigating the regulation of gene expression in differentiated cells. The cells that are reprogrammed in heterokaryons should provide useful test systems for studying the mechanisms of action of the relevant molecules. Differences among cell types in the lag period before gene expression, the time course of accumulation of gene products, and the frequencies of gene expression at different nuclear ratios suggest different mechanistic steps. These could result from differences in gene conformation due to DNA modifications or binding proteins in addition to differences in the requirement for the type, concentration, or stoichiometry of trans-acting factors. We and others have begun to characterize the cis-acting regulatory sequences of muscle-specific genes (44) . The isolation of the genes for trans-acting muscle-regulatory molecules at determined, differentiated, and mature stages of muscle development should now also be possible. Approaches that may prove useful for isolating mRNA's and genes for uncharacterized factors include microinjection of cytoplasmic components, use of subtractive hybridization to enrich for mRNA's for stage-specific regulators, and transfection of either cDNA's made to the enriched mRNA's or of genomic DNA into cells in conjunction with selective assays for gene expression (45) . Elucidation of the molecular mechanisms underlying the reprogramming of nonmuscle cell types should lead to a better understanding of the generation and maintenance of these phenotypes and of different myogenic stages.
isolated and karyotyped in our laboratory and selected for its ability to differentiate rapidly and produce extensive contracting myotubes expressing characteristic muscle proteins. Where indicated, a myogenic derivative of a IOTI/2 cell provided by A. Lassar and H. Weintraub was used. Heterokaryons were produced with polyethylene glycol (PEG) (10) and maintained in a medium containing the selective agents cytosine arabinoside (Ara-C) and ouabain to eliminate unfused cells. 14. Tissue-specific cell types included chondrocytes isolated in our laboratory from neonatal carti- ine the accumulation of human a-cardiac actin transcripts in heterokaryons, a second cDNA probe was used, which was species-and isotype-specific: at the hybridization stringency used, only human a-cardiac actin transcripts were detected (Fig. 4) . To examine the expression of the mouse cardiac actin gene in the same heterokaryons, the RNA from the heterokaryons was subjected to SI nuclease analysis. We used a third probe, which shared homology with a longer sequence of human than mouse acardiac actin mRNA. Thus, the sequences for mouse and human that hybridized well and were protected from treatment with S1, an enzyme 
